APO RESEARCH · REPORT
Bone and Joint Health Supplements
Bone and Joint Health Supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid, for bone and joint.
Product & engineering
Understand the product.
Bone and Joint Health Supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid, for bone and joint.
This report focuses on the 2C market.
Selected research
Market Outlook & Growth Opportunities
Global Bone and Joint Health Supplements Market Outlook and Growth Opportunities 2026
Market perspective
Bone and Joint Health Supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid, for bone and joint.
This report focuses on the 2C market.
Global key players of Bone and Joint Health Supplements include Nature's Bounty, GSK-Pfizer, By-Health, Nature Made and Schiff, etc. Top five players occupy for a share about 38%. North America is the largest market, with a share about 38%, followed by Asia-Pacific and Europe. In terms of product, Calcium and Vitamin D3 is the largest segment, with a share over 59%. In terms of application, Below 12 Years Old is the largest market, with a share over 29%.
Read the full market overview
This report provides an overview of the global Bone and Joint Health Supplements market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bone and Joint Health Supplements and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bone and Joint Health Supplements revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bone and Joint Health Supplements market.
Bone and Joint Health Supplements Segment by Company
Swisse
GSK-Pfizer
A&Z Pharmaceutical
Amway (Nutrilite)
Shanxi Zhendong Pharmaceutical
Nature Made
By-Health
Harbin Pharmaceutical Group
Bayer
GNC Holdings
Bio Island
Nature's Bounty
High Change
Bluebonnet Nutrition
Schiff
Solgar
BioTrust Nutrition
Pure Encapsulations
NOW Foods
Blackmores
Bone and Joint Health Supplements Segment by Type
Calcium and Vitamin D3
Omega-3 (Fish Oil)
Glucosamine and Chondroitin
Magnesium
Collagen
Turmeric
Others
Bone and Joint Health Supplements Segment by Application
Below 12 Years Old
12-18 Years Old
19-49 Years Old
50-60 Years Old
Above 60 Years Old
Bone and Joint Health Supplements Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Bone and Joint Health Supplements status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bone and Joint Health Supplements key companies, revenue, market share, and recent developments.
3. To split the Bone and Joint Health Supplements breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bone and Joint Health Supplements market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bone and Joint Health Supplements significant trends, drivers, influence factors in global and regions.
6. To analyze Bone and Joint Health Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone and Joint Health Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bone and Joint Health Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone and Joint Health Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone and Joint Health Supplements industry.
Chapter 3: Detailed analysis of Bone and Joint Health Supplements company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bone and Joint Health Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bone and Joint Health Supplements in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Calcium and Vitamin D3
- Omega-3 (Fish Oil)
- Glucosamine and Chondroitin
- Magnesium
- Collagen
- Turmeric
- Others
Applications
- Below 12 Years Old
- 12-18 Years Old
- 19-49 Years Old
- 50-60 Years Old
- Above 60 Years Old
Companies covered
- Swisse
- GSK-Pfizer
- A&Z Pharmaceutical
- Amway (Nutrilite)
- Shanxi Zhendong Pharmaceutical
- Nature Made
- By-Health
- Harbin Pharmaceutical Group
- Bayer
- GNC Holdings
- Bio Island
- Nature's Bounty
- High Change
- Bluebonnet Nutrition
- Schiff
- Solgar
- BioTrust Nutrition
- Pure Encapsulations
- NOW Foods
- Blackmores
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bone and Joint Health Supplements Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bone and Joint Health Supplements Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Bone and Joint Health Supplements Market Dynamics
- 2.1 Bone and Joint Health Supplements Industry Trends
- 2.2 Bone and Joint Health Supplements Industry Drivers
- 2.3 Bone and Joint Health Supplements Industry Opportunities and Challenges
- 2.4 Bone and Joint Health Supplements Industry Restraints
3 Bone and Joint Health Supplements Market by Company
- 3.1 Global Bone and Joint Health Supplements Company Revenue Ranking in 2025
- 3.2 Global Bone and Joint Health Supplements Revenue by Company (2021-2026)
- 3.3 Global Bone and Joint Health Supplements Company Ranking (2024-2026)
- 3.4 Global Bone and Joint Health Supplements Company Manufacturing Base and Headquarters
- 3.5 Global Bone and Joint Health Supplements Company Product Type and Application
- 3.6 Global Bone and Joint Health Supplements Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Bone and Joint Health Supplements Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Bone and Joint Health Supplements Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Bone and Joint Health Supplements Market by Type
- 4.1 Bone and Joint Health Supplements Type Introduction
- 4.1.1 Calcium and Vitamin D3
- 4.1.2 Omega-3 (Fish Oil)
- 4.1.3 Glucosamine and Chondroitin
- 4.1.4 Magnesium
- 4.1.5 Collagen
- 4.1.6 Turmeric
- 4.1.7 Others
- 4.2 Global Bone and Joint Health Supplements Sales Value by Type
- 4.2.1 Global Bone and Joint Health Supplements Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bone and Joint Health Supplements Sales Value by Type (2021-2032)
- 4.2.3 Global Bone and Joint Health Supplements Sales Value Share by Type (2021-2032)
5 Bone and Joint Health Supplements Market by Application
- 5.1 Bone and Joint Health Supplements Application Introduction
- 5.1.1 Below 12 Years Old
- 5.1.2 12-18 Years Old
- 5.1.3 19-49 Years Old
- 5.1.4 50-60 Years Old
- 5.1.5 Above 60 Years Old
- 5.2 Global Bone and Joint Health Supplements Sales Value by Application
- 5.2.1 Global Bone and Joint Health Supplements Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bone and Joint Health Supplements Sales Value by Application (2021-2032)
- 5.2.3 Global Bone and Joint Health Supplements Sales Value Share by Application (2021-2032)
6 Bone and Joint Health Supplements Regional Value Analysis
- 6.1 Global Bone and Joint Health Supplements Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bone and Joint Health Supplements Sales Value by Region (2021-2032)
- 6.2.1 Global Bone and Joint Health Supplements Sales Value by Region: 2021-2026
- 6.2.2 Global Bone and Joint Health Supplements Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bone and Joint Health Supplements Sales Value (2021-2032)
- 6.3.2 North America Bone and Joint Health Supplements Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Bone and Joint Health Supplements Sales Value (2021-2032)
- 6.4.2 Europe Bone and Joint Health Supplements Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Bone and Joint Health Supplements Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Bone and Joint Health Supplements Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Bone and Joint Health Supplements Sales Value (2021-2032)
- 6.6.2 South America Bone and Joint Health Supplements Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Bone and Joint Health Supplements Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Bone and Joint Health Supplements Sales Value Share by Country, 2025 VS 2032
7 Bone and Joint Health Supplements Country-level Value Analysis
- 7.1 Global Bone and Joint Health Supplements Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Bone and Joint Health Supplements Sales Value by Country (2021-2032)
- 7.2.1 Global Bone and Joint Health Supplements Sales Value by Country (2021-2026)
- 7.2.2 Global Bone and Joint Health Supplements Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.7.2 France Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.14.2 China Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.17.2 India Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Bone and Joint Health Supplements Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Bone and Joint Health Supplements Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Bone and Joint Health Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Swisse
- 8.1.1 Swisse Company Information
- 8.1.2 Swisse Business Overview
- 8.1.3 Swisse Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.1.4 Swisse Bone and Joint Health Supplements Product Portfolio
- 8.1.5 Swisse Recent Developments
- 8.2 GSK-Pfizer
- 8.2.1 GSK-Pfizer Company Information
- 8.2.2 GSK-Pfizer Business Overview
- 8.2.3 GSK-Pfizer Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.2.4 GSK-Pfizer Bone and Joint Health Supplements Product Portfolio
- 8.2.5 GSK-Pfizer Recent Developments
- 8.3 A&Z Pharmaceutical
- 8.3.1 A&Z Pharmaceutical Company Information
- 8.3.2 A&Z Pharmaceutical Business Overview
- 8.3.3 A&Z Pharmaceutical Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.3.4 A&Z Pharmaceutical Bone and Joint Health Supplements Product Portfolio
- 8.3.5 A&Z Pharmaceutical Recent Developments
- 8.4 Amway (Nutrilite)
- 8.4.1 Amway (Nutrilite) Company Information
- 8.4.2 Amway (Nutrilite) Business Overview
- 8.4.3 Amway (Nutrilite) Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.4.4 Amway (Nutrilite) Bone and Joint Health Supplements Product Portfolio
- 8.4.5 Amway (Nutrilite) Recent Developments
- 8.5 Shanxi Zhendong Pharmaceutical
- 8.5.1 Shanxi Zhendong Pharmaceutical Company Information
- 8.5.2 Shanxi Zhendong Pharmaceutical Business Overview
- 8.5.3 Shanxi Zhendong Pharmaceutical Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.5.4 Shanxi Zhendong Pharmaceutical Bone and Joint Health Supplements Product Portfolio
- 8.5.5 Shanxi Zhendong Pharmaceutical Recent Developments
- 8.6 Nature Made
- 8.6.1 Nature Made Company Information
- 8.6.2 Nature Made Business Overview
- 8.6.3 Nature Made Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.6.4 Nature Made Bone and Joint Health Supplements Product Portfolio
- 8.6.5 Nature Made Recent Developments
- 8.7 By-Health
- 8.7.1 By-Health Company Information
- 8.7.2 By-Health Business Overview
- 8.7.3 By-Health Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.7.4 By-Health Bone and Joint Health Supplements Product Portfolio
- 8.7.5 By-Health Recent Developments
- 8.8 Harbin Pharmaceutical Group
- 8.8.1 Harbin Pharmaceutical Group Company Information
- 8.8.2 Harbin Pharmaceutical Group Business Overview
- 8.8.3 Harbin Pharmaceutical Group Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.8.4 Harbin Pharmaceutical Group Bone and Joint Health Supplements Product Portfolio
- 8.8.5 Harbin Pharmaceutical Group Recent Developments
- 8.9 Bayer
- 8.9.1 Bayer Company Information
- 8.9.2 Bayer Business Overview
- 8.9.3 Bayer Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.9.4 Bayer Bone and Joint Health Supplements Product Portfolio
- 8.9.5 Bayer Recent Developments
- 8.10 GNC Holdings
- 8.10.1 GNC Holdings Company Information
- 8.10.2 GNC Holdings Business Overview
- 8.10.3 GNC Holdings Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.10.4 GNC Holdings Bone and Joint Health Supplements Product Portfolio
- 8.10.5 GNC Holdings Recent Developments
- 8.11 Bio Island
- 8.11.1 Bio Island Company Information
- 8.11.2 Bio Island Business Overview
- 8.11.3 Bio Island Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.11.4 Bio Island Bone and Joint Health Supplements Product Portfolio
- 8.11.5 Bio Island Recent Developments
- 8.12 Nature's Bounty
- 8.12.1 Nature's Bounty Company Information
- 8.12.2 Nature's Bounty Business Overview
- 8.12.3 Nature's Bounty Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.12.4 Nature's Bounty Bone and Joint Health Supplements Product Portfolio
- 8.12.5 Nature's Bounty Recent Developments
- 8.13 High Change
- 8.13.1 High Change Company Information
- 8.13.2 High Change Business Overview
- 8.13.3 High Change Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.13.4 High Change Bone and Joint Health Supplements Product Portfolio
- 8.13.5 High Change Recent Developments
- 8.14 Bluebonnet Nutrition
- 8.14.1 Bluebonnet Nutrition Company Information
- 8.14.2 Bluebonnet Nutrition Business Overview
- 8.14.3 Bluebonnet Nutrition Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.14.4 Bluebonnet Nutrition Bone and Joint Health Supplements Product Portfolio
- 8.14.5 Bluebonnet Nutrition Recent Developments
- 8.15 Schiff
- 8.15.1 Schiff Company Information
- 8.15.2 Schiff Business Overview
- 8.15.3 Schiff Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.15.4 Schiff Bone and Joint Health Supplements Product Portfolio
- 8.15.5 Schiff Recent Developments
- 8.16 Solgar
- 8.16.1 Solgar Company Information
- 8.16.2 Solgar Business Overview
- 8.16.3 Solgar Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.16.4 Solgar Bone and Joint Health Supplements Product Portfolio
- 8.16.5 Solgar Recent Developments
- 8.17 BioTrust Nutrition
- 8.17.1 BioTrust Nutrition Company Information
- 8.17.2 BioTrust Nutrition Business Overview
- 8.17.3 BioTrust Nutrition Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.17.4 BioTrust Nutrition Bone and Joint Health Supplements Product Portfolio
- 8.17.5 BioTrust Nutrition Recent Developments
- 8.18 Pure Encapsulations
- 8.18.1 Pure Encapsulations Company Information
- 8.18.2 Pure Encapsulations Business Overview
- 8.18.3 Pure Encapsulations Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.18.4 Pure Encapsulations Bone and Joint Health Supplements Product Portfolio
- 8.18.5 Pure Encapsulations Recent Developments
- 8.19 NOW Foods
- 8.19.1 NOW Foods Company Information
- 8.19.2 NOW Foods Business Overview
- 8.19.3 NOW Foods Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.19.4 NOW Foods Bone and Joint Health Supplements Product Portfolio
- 8.19.5 NOW Foods Recent Developments
- 8.20 Blackmores
- 8.20.1 Blackmores Company Information
- 8.20.2 Blackmores Business Overview
- 8.20.3 Blackmores Bone and Joint Health Supplements Revenue and Gross Margin (2021-2026)
- 8.20.4 Blackmores Bone and Joint Health Supplements Product Portfolio
- 8.20.5 Blackmores Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst